Article Text

Download PDFPDF

O12.6 Quality assessment of the enhanced gonococcal antimicrobial surveillance program in thailand, 2015–2016
  1. Emily Weston1,
  2. Sirirat Lertpruek2,
  3. Jaray Tongtoyai2,
  4. Prisana Buasakul1,
  5. Wichuda Sukwicha1,
  6. Wannee Chonwattana1,
  7. Emily Weston3,
  8. Eileen Dunne4,
  9. Pachara Sirivongrangsan5
  1. 1Bangkok STIs Centre, Bureau of Aids/Tb/STIs, Dept of Disease Control, Thailand Ministry of Health, Bangkok, Thailand
  2. 2HIV/STD Research Program, Thailand Ministry of Health, Us Centres For Disease Control Collaboration, Bangkok, Thailand
  3. 3Division of STD Prevention, US Centres For Disease Control and Prevention, Atlanta, USA
  4. 4Division of Hiv/Aids Prevention, Us Centres For Disease Control and Prevention, Atlanta, USA
  5. 5Department of Disease Control and Prevention, Thailand Ministry of Health, Bangkok, Thailand


Introduction Antimicrobial resistant Neisseria gonorrhoea (NG) is important to monitor as a potential global public health threat. The Thailand Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) was started in November 2015 as a collaboration between the Thailand Ministry of Public Health, the US Centres for Disease Control and Prevention and the World Health Organisation. As a part of this surveillance activity, Thailand conducted an internal quality assessment (QA) of clinical and laboratory data in order to improve surveillance data quality.

Methods EGASP Thailand occurs in 2 sentinel sites: Bangrak Hospital and Silom Community Clinic at Tropical Medicine. Men with symptoms had demographic and clinical data collected as well as a urethral specimen collected for NG culture. A random selection of 10% of EGASP IDs were sampled from November 2015 to June 2016. We assessed clinical and laboratory findings using a standardised review tool that compared the EGASP database to source documents. We describe key findings from the review activities.

Results Overall, 699 specimens were collected for EGASP and 70 (10%) EGASP IDs were randomly sampled by SQL command for review. Results from the quality review included: differences in laboratory findings (6%), differences in interpretation of the clinical abstraction tool between sentinel sites (10%), missing data in the EGASP database after chart abstraction and laboratory testing (14%), differences in the recording of clinical data (19%), and differences in the recording and tracking of laboratory variables (47%). As a result of this evaluation, staff updated missing data on records sampled, conducted an overall refresher training for staff and established a new laboratory tracking process.

Conclusion EGASP Thailand is the first coordinated global project to conduct comprehensive surveillance for NG resistance from symptomatic men. An internal QA helped direct efforts to improve surveillance. Ongoing NG surveillance and periodic quality assessments help ensure high quality surveillance data.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles